153 related articles for article (PubMed ID: 14592544)
1. Studies on the mechanism of action of anti-inflammatory drugs. A paper in honour of John Vane.
Flower RJ
Thromb Res; 2003 Jun; 110(5-6):259-63. PubMed ID: 14592544
[No Abstract] [Full Text] [Related]
2. The mechanism of action of aspirin.
Vane JR; Botting RM
Thromb Res; 2003 Jun; 110(5-6):255-8. PubMed ID: 14592543
[TBL] [Abstract][Full Text] [Related]
3. COX-1 and COX-3 inhibitors.
Botting R
Thromb Res; 2003 Jun; 110(5-6):269-72. PubMed ID: 14592546
[TBL] [Abstract][Full Text] [Related]
4. Selective cyclooxygenase 2 inhibitors, aspirin, and cardiovascular disease: a reappraisal.
Baigent C; Patrono C
Arthritis Rheum; 2003 Jan; 48(1):12-20. PubMed ID: 12528099
[No Abstract] [Full Text] [Related]
5. Spinal synthesis and release of prostanoids after peripheral injury and inflammation.
Dirig DM; Yaksh TL
Adv Exp Med Biol; 1999; 469():401-8. PubMed ID: 10667359
[No Abstract] [Full Text] [Related]
6. Control of COX-2 and iNOS gene expressions by aspirin and salicylate.
Wu KK
Thromb Res; 2003 Jun; 110(5-6):273-6. PubMed ID: 14592547
[No Abstract] [Full Text] [Related]
7. Prostanoids and inflammatory pain.
Chen L; Yang G; Grosser T
Prostaglandins Other Lipid Mediat; 2013; 104-105():58-66. PubMed ID: 22981510
[TBL] [Abstract][Full Text] [Related]
8. Aspirin and related nonsteroidal anti-inflammatory drugs as chemopreventive agents against colon cancer.
Marnett LJ
Prev Med; 1995 Mar; 24(2):103-6. PubMed ID: 7597006
[No Abstract] [Full Text] [Related]
9. Cyclooxygenase-2 inhibitors: promise or peril?
Mengle-Gaw LJ; Schwartz BD
Mediators Inflamm; 2002 Oct; 11(5):275-86. PubMed ID: 12467519
[TBL] [Abstract][Full Text] [Related]
10. Dual acting anti-inflammatory drugs: a reappraisal.
Bertolini A; Ottani A; Sandrini M
Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
[TBL] [Abstract][Full Text] [Related]
11. Microsomal prostaglandin E2 synthase: a safer target than cyclooxygenases?
Timmers L; Pasterkamp G; de Kleijn DP
Mol Interv; 2007 Aug; 7(4):195-9, 180. PubMed ID: 17827439
[TBL] [Abstract][Full Text] [Related]
12. Nonsteroidal anti-inflammatory drugs and the gastrointestinal tract: consensus and controversy. Introduction.
Hawkey CJ
Am J Med; 2001 Jan; 110(1A):1S-3S. PubMed ID: 11165986
[No Abstract] [Full Text] [Related]
13. [Cyclooxygenase-1 and cyclooxygenase-2--important for the clinicians?].
Kvien TK; Giercksky KE; Rugstad HE
Tidsskr Nor Laegeforen; 1998 Apr; 118(11):1684-5. PubMed ID: 9621754
[No Abstract] [Full Text] [Related]
14. Mechanism of action of anti-inflammatory drugs.
Vane JR; Botting RM
Adv Exp Med Biol; 1997; 433():131-8. PubMed ID: 9561120
[No Abstract] [Full Text] [Related]
15. Aspirin intolerance.
Morassut P; Yang W; Karsh J
Semin Arthritis Rheum; 1989 Aug; 19(1):22-30. PubMed ID: 2505388
[No Abstract] [Full Text] [Related]
16. Late preconditioning against myocardial stunning. Does aspirin close the "second window" of endogenous cardioprotection?
Przyklenk K; Heusch G
J Am Coll Cardiol; 2003 Apr; 41(7):1195-7. PubMed ID: 12679221
[No Abstract] [Full Text] [Related]
17. Inhibitors of cyclooxygenases: mechanisms, selectivity and uses.
Botting RM
J Physiol Pharmacol; 2006 Nov; 57 Suppl 5():113-24. PubMed ID: 17218763
[TBL] [Abstract][Full Text] [Related]
18. The molecular perspective: cyclooxygenase-2.
Goodsell DS
Oncologist; 2000; 5(2):169-71. PubMed ID: 10794808
[No Abstract] [Full Text] [Related]
19. [Clinical pharmacology of selective inhibitors of cyclooxygenase-2].
Patrignani P
Acta Otorhinolaryngol Ital; 2003 Aug; 23(4 Suppl 74):13-8, 37-40. PubMed ID: 15058604
[No Abstract] [Full Text] [Related]
20. The effects of aspirin on gastric mucosal integrity, surface hydrophobicity, and prostaglandin metabolism in cyclooxygenase knockout mice.
Darling RL; Romero JJ; Dial EJ; Akunda JK; Langenbach R; Lichtenberger LM
Gastroenterology; 2004 Jul; 127(1):94-104. PubMed ID: 15236176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
